You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Current status of use of high throughput nucleotide sequencing in rheumatology

http://dx.doi.org/10.1136/rmdopen-2020-001324corr1

Statistics from Altmetric.com

    Boegel S, Castle JC, Schwarting A. Current status of use of high throughput nucleotide sequencing in rheumatology. RMD Open 2021;7:e001324. doi: 10.1136/rmdopen-2020-001324

    The article has been corrected since it was published online. The funding statement has been updated as follows.

    We wish to acknowledge the RARENET EU-Interreg for supporting this study. Furthermore, SB wishes to acknowledge and thank the Mainz Research School of Translational Biomedicine (TransMed) for support.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.